Recon: Sangamo Buys TxCell for $84M; China Probes Vaccine Manufacturer

• FDA staff raises efficacy doubts on GSK's lung disease treatment (Reuters) (Endpoints)
• Sanofi Ventures leads $17m round for Click Therapeutics (DDBN) (Fierce)
• Court Says Allergan Can't Shield Restasis Patents With Tribe (Bloomberg) (STAT-$) (Reuters)
• Theranos Settles Investor Suit as Funds Run Low (WSJ)
• Million-person genetic study finds gene patterns linked to how long people stay in school (MIT Tech Review)
• Analysts Expect Drug Supplier Whiplash To Endure on Rebate Changes (Bloomberg)
• In lawsuit, Human Longevity alleges that Craig Venter stole trade secrets (STAT)

• Sangamo Bags TxCell, and a Next-Gen Cell Therapy Tech, for $84M (Xconomy) (Fierce) (GEN)
• Chinese authorities to carry out surprise checks on vaccine makers, as Premier Li Keqiang calls for severe punishment (The Straits Times) (Reuters) (The Guardian)
• China’s pharma scandals sully healthcare cleanup (Reuters)
• Vaccine Scandal Brings China’s Drugs Stocks Back Down to Earth (Bloomberg-$)
• Philips says sales growth to improve after China causes Q2 miss (Reuters) (Bloomberg)
• Commission Staff Working Document on Combatting HIV/AIDS, viral hepatitis and tuberculosis: sustained effort needed to meet 2030 goals (EC)

• Trump battle over drug prices heats up (The Hill) (Politico)
• Pharmaceutical Companies Seek Stability in Trump Drug Cost Fight (Bloomberg)
• Health, Drug Lobbying Slows After Big-Spending Start to Year (Bloomberg BNA)
• Who's Promised What: A Guide To Pharma Drug Pricing Pledges (Scrip-$)
• Is It Checkmate For Pharma's Epic Gaming Of Patents? (ACSH)
• Unpacking the bold — and the bluster — in Trump’s plan to bring down drug prices (STAT)
• FDA’s new ruling on biosimilars could spur Triangle manufacturing (Triangle Business Journal-$)
• Cambrex to Acquire Halo Pharma, Adding Drug Development and Finished Dosage Capabilities to Global API Manufacturing Network (Press)
• Bristol-Myers Squibb Announces Departure of Chief Commercial Officer (Press)
• Isogenica Licenses CIS Display Technology to Aro Biotherapeutics for Centyrin-based Biopharmaceutical Development (Press)

• Top Alzheimer’s researchers hope that near-100 dementia drugs in trials are moving closer to a breakthrough (CNBC)
• Amneal Announces FDA Approval and Launch of Generic Potassium Chloride Oral Solution (Press)
• Aerie Pharmaceuticals Announces Early Notification of FDA Acceptance of NDA Submission for Roclatan (netarsudil/latanoprost ophthalmic solution) 0.02%/0.005% with PDUFA Date Set for March 14, 2019 (Press)
• Acceleron Announces Preliminary Results from Part 1 of the ACE-083 Phase 2 Trial in Patients with Charcot-Marie-Tooth Disease at the 2018 Annual Meeting of the Peripheral Nerve Society (Press)
• Alnylam Presents New Analyses of Clinical Results from APOLLO Phase 3 Study of Patisiran at 2018 Peripheral Nerve Society Annual Meeting (Press)
• Aura Biosciences Presents Interim Phase 1b/2 Data at the American Society of Retina Specialists (ASRS) Annual Meeting (Press)
• Alzheon Presents New Findings in APOE4/4 Homozygous Patients with Mild Alzheimer’s Disease, Further Supporting Precision Medicine Approach and Planned Confirmatory Clinical Trial with ALZ-801 (Press)

• House panel to vote today on medical device tax repeal (MassDevice)
• Repeal of medical device tax would support medical technology innovation (The Hill)
• A tax on medical devices makes no sense. It’s time to eliminate it for good (STAT)
• MITA urges Congress to permanently repeal the medical device tax (MITA)
• MIT, Harvard Face New Challenge to Gene-Editing Patent (Bloomberg-$)
• Medical Devices Are Going Mobile, but Makers Face Barriers (Bloomberg-$)
• NIH Clinical Center releases dataset of 32,000 CT images (NIH)
• Statement from FDA Commissioner Scott Gottlieb, M.D., on manufacturer announcement to halt Essure sales in the U.S.; agency’s continued commitment to postmarket review of Essure and keeping women informed (FDA)
• MEDICALgorithmics, Medi-Lynx Receive FDA 510(K) Clearance for PocketECG CRS Mobile Cardiac Rehabilitation System (Press)

• A move to undermine women’s reproductive health (The Hill)
• Senate set to confirm Wilkie for Veterans Affairs secretary (AP News)
• Sniffles? Cancer? Under Medicare Plan, Payments for Office Visits Would Be Same for Both (NYT)
• 70 Democrats Sign On to New ‘Medicare for All’ House Caucus (The Daily Beast)
• FDA’s Product Jurisdiction Proposal: More Changes are Needed (FDA Law Blog)
• Pharmacy Compounding Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments (FDA)
• Regulatory Perspectives on Otic and Vestibular Toxicity: Challenges in Translating Animal Studies to Human Risk Assessment; Public Workshop (FDA)

• FDA Advisory Committee Calendar

• Abbott to add 500 new jobs at Donegal healthcare plant (The Irish Times)
• Roche wins CE Mark for Accu-Chek Solo insulin micropump (DDBN)
• First generation JOURNEY BCS Knee System– Higher than expected risk of revision (MDA/2018/026) (MHRA)
• Updated: Suspended and revoked licences and registrations for manufacturers and wholesalers of medicines and ingredients (MHRA)
• Updated: Field safety notices - 16 to 20 July 2018 (MHRA)
• Out-of-stock - Tepadina, powder for solution for infusion (swissmedic)
• Committee for medicinal products for human use (CHMP): Draft agenda for the meeting on 23-26 July 2018 (EMA)
• Accounting Officer’s certificate on the annual accounts for the financial year 2017 (EMA)
• Omeros Corporation Initiates Sales of OMIDRIA in Europe (Press)
• Owen Mumford Launches New HIV Rapid Testing to European Markets (Press)

• Singapore Hack Is a Speed Bump for $9 Trillion Industry (Bloomberg)
• 3D Printer of PEKK Implants Expanding in Asia (MD+DI)
• Expert forum: Revising the law for the system of medical device listing permit holder (China Association for Medical Devices Industry)
• SanBio: Joint Research Agreement for SB623 Targeting Dementia (Press)

• CDSCO concludes 15 inspections in Maharashtra, MP, Chattisgarh, Gujarat and Goa towards implementing new MD Rules (Pharmabiz)

• Johnson & Johnson’s DePuy to incorporate wearable tech into total knee replacements in Australia and New Zealand (Fierce)

• Eye on Drug Charities • Clinical Trials in Canada (Bloomberg-$)

• Regulation: Portal allows monitoring issues for 2018 (Anvisa)
• Burden of disease in Brazil, 1990–2016: a systematic subnational analysis for the Global Burden of Disease Study 2016 (The Lancet)
• Zika epidemic sheds light on Brazil's 'invisible children' (The Guardian)

• A big overlooked flaw with health tech: Patients hate going to the doctor (CNBC)
• LifePoint Health Agrees to Apollo Buyout (WSJ)
• Anthem In Telehealth Deal With Samsung And American Well (Forbes)
• One Man’s $50 Billion Vendetta Against Opioids (Bloomberg)